Matthew P. Bourbeau

973 total citations
16 papers, 433 citations indexed

About

Matthew P. Bourbeau is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Matthew P. Bourbeau has authored 16 papers receiving a total of 433 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Organic Chemistry, 8 papers in Molecular Biology and 3 papers in Pharmacology. Recurrent topics in Matthew P. Bourbeau's work include Synthetic Organic Chemistry Methods (5 papers), Alkaloids: synthesis and pharmacology (2 papers) and PI3K/AKT/mTOR signaling in cancer (2 papers). Matthew P. Bourbeau is often cited by papers focused on Synthetic Organic Chemistry Methods (5 papers), Alkaloids: synthesis and pharmacology (2 papers) and PI3K/AKT/mTOR signaling in cancer (2 papers). Matthew P. Bourbeau collaborates with scholars based in United States. Matthew P. Bourbeau's co-authors include James A. Marshall, Michael D. Bartberger, David J. St. Jean, Jie Yan, Kate S. Ashton, John G. Allen, Aaron C. Siegmund, Dean Hickman, Christopher Fotsch and Paul H. Wen and has published in prestigious journals such as Cancer Research, Journal of Medicinal Chemistry and The Journal of Organic Chemistry.

In The Last Decade

Matthew P. Bourbeau

15 papers receiving 426 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthew P. Bourbeau United States 13 302 142 58 41 40 16 433
A. Mayweg Switzerland 13 308 1.0× 189 1.3× 117 2.0× 27 0.7× 43 1.1× 19 576
James C. Lanter United States 18 392 1.3× 180 1.3× 37 0.6× 26 0.6× 16 0.4× 34 584
Vincent J. Colandrea United States 11 280 0.9× 147 1.0× 39 0.7× 25 0.6× 12 0.3× 13 459
Alec D. Lebsack United States 8 268 0.9× 107 0.8× 36 0.6× 33 0.8× 32 0.8× 15 374
Malken Bayrakdarian Canada 13 239 0.8× 146 1.0× 47 0.8× 16 0.4× 42 1.1× 17 390
Ashley Fenwick United Kingdom 12 310 1.0× 260 1.8× 91 1.6× 17 0.4× 32 0.8× 19 572
Candido Gude United States 12 487 1.6× 196 1.4× 67 1.2× 14 0.3× 50 1.3× 24 670
T. MUKAIYAMA Japan 12 438 1.5× 110 0.8× 68 1.2× 43 1.0× 11 0.3× 24 523
Kent Neuenschwander United States 12 248 0.8× 181 1.3× 32 0.6× 21 0.5× 55 1.4× 19 446
Ge Hyeong Lee South Korea 11 342 1.1× 96 0.7× 51 0.9× 22 0.5× 14 0.3× 26 439

Countries citing papers authored by Matthew P. Bourbeau

Since Specialization
Citations

This map shows the geographic impact of Matthew P. Bourbeau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew P. Bourbeau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew P. Bourbeau more than expected).

Fields of papers citing papers by Matthew P. Bourbeau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew P. Bourbeau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew P. Bourbeau. The network helps show where Matthew P. Bourbeau may publish in the future.

Co-authorship network of co-authors of Matthew P. Bourbeau

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew P. Bourbeau. A scholar is included among the top collaborators of Matthew P. Bourbeau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew P. Bourbeau. Matthew P. Bourbeau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Belmontes, Brian, Siyuan Liu, Jodi Moriguchi, et al.. (2022). Abstract 1807: The discovery and preclinical characterization of the MTA cooperative PRMT5 inhibitor AM-9747. Cancer Research. 82(12_Supplement). 1807–1807. 4 indexed citations
2.
Frohn, Michael, Longbin Liu, Aaron C. Siegmund, et al.. (2020). The development of a structurally distinct series of BACE1 inhibitors via the (Z)-fluoro-olefin amide bioisosteric replacement. Bioorganic & Medicinal Chemistry Letters. 30(14). 127240–127240. 4 indexed citations
3.
Pettus, Liping H., Matthew P. Bourbeau, Michael D. Bartberger, et al.. (2019). Discovery of AM-6494: A Potent and Orally Efficacious β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitor with in Vivo Selectivity over BACE2. Journal of Medicinal Chemistry. 63(5). 2263–2281. 28 indexed citations
4.
Bourbeau, Matthew P. & Michael D. Bartberger. (2014). Recent Advances in the Development of Acetyl-CoA Carboxylase (ACC) Inhibitors for the Treatment of Metabolic Disease. Journal of Medicinal Chemistry. 58(2). 525–536. 49 indexed citations
5.
Bourbeau, Matthew P., Kate S. Ashton, Jie Yan, & David J. St. Jean. (2014). Nonracemic Synthesis of GK–GKRP Disruptor AMG-3969. The Journal of Organic Chemistry. 79(8). 3684–3687. 21 indexed citations
6.
Harrington, Paul E., Matthew P. Bourbeau, Christopher Fotsch, et al.. (2013). The optimization of aminooxadiazoles as orally active inhibitors of Cdc7. Bioorganic & Medicinal Chemistry Letters. 23(23). 6396–6400. 14 indexed citations
7.
Bourbeau, Matthew P., Aaron Siegmund, John G. Allen, et al.. (2013). Piperazine Oxadiazole Inhibitors of Acetyl-CoA Carboxylase. Journal of Medicinal Chemistry. 56(24). 10132–10141. 16 indexed citations
8.
Zeng, Qingping, Matthew P. Bourbeau, Holger Monenschein, et al.. (2010). 2-Aminothiadiazole inhibitors of AKT1 as potential cancer therapeutics. Bioorganic & Medicinal Chemistry Letters. 20(5). 1652–1656. 15 indexed citations
9.
10.
Bourbeau, Matthew P., et al.. (2006). A Convenient Synthesis of 4-Alkyl-5-aminoisoxazoles. Organic Letters. 8(17). 3679–3680. 51 indexed citations
11.
Marshall, James A., et al.. (2005). Leptostatin: A synthetic hybrid of the cytotoxic polyketides callystatin A and leptomycin B. Bioorganic & Medicinal Chemistry Letters. 16(2). 320–323. 12 indexed citations
12.
Marshall, James A. & Matthew P. Bourbeau. (2003). Synthesis of Enantioenriched Propargylic Alcohols Related to Polyketide Natural Products. A Comparison of Methodologies. Organic Letters. 5(18). 3197–3199. 81 indexed citations
13.
Marshall, James A. & Matthew P. Bourbeau. (2003). Directed Pd(0)-catalyzed hydrostannations of internal alkynes. Tetrahedron Letters. 44(5). 1087–1089. 15 indexed citations
14.
Marshall, James A. & Matthew P. Bourbeau. (2002). Total Synthesis of (‐)‐Callystatin A.. ChemInform. 33(51). 212–212.
15.
Marshall, James A. & Matthew P. Bourbeau. (2002). Second-Generation Synthesis of the Polypropionate Subunit of Callystatin A Based on Regioselective Internal Alkyne Hydrostannation. Organic Letters. 4(22). 3931–3934. 30 indexed citations
16.
Marshall, James A. & Matthew P. Bourbeau. (2001). Total Synthesis of (−)-Callystatin A. The Journal of Organic Chemistry. 67(9). 2751–2754. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. Mayweg Breakdown of academic impact, for papers by James C. Lanter Breakdown of academic impact, for papers by Vincent J. Colandrea Breakdown of academic impact, for papers by Alec D. Lebsack Breakdown of academic impact, for papers by Malken Bayrakdarian Breakdown of academic impact, for papers by Ashley Fenwick Breakdown of academic impact, for papers by Candido Gude Breakdown of academic impact, for papers by T. MUKAIYAMA Breakdown of academic impact, for papers by Kent Neuenschwander Breakdown of academic impact, for papers by Ge Hyeong Lee
Rankless by CCL
2026